Cellular Immune Suppression in Paraneoplastic Neurologic Syndromes Targeting Intracellular Antigens

BACKGROUND: Tumor treatment is the mainstay of therapy for paraneoplastic neurologic disorders (PNDs), but it is only effective in some cases and other treatment options are limited. OBJECTIVE: To evaluate the short-term use of a combination of prednisone and tacrolimus for acute neurologic worsenin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Orange, Dana, Frank, Mayu, Tian, Suyan, Dousmanis, Athanasios, Marmur, Ronen, Buckley, Noreen, Parveen, Salina, Graber, Jerome J., Blachère, Nathalie, Darnell, Robert B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3721351/
https://ncbi.nlm.nih.gov/pubmed/22566506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2012.595
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak